Details for Patent: 7,977,376
✉ Email this page to a colleague
Summary for Patent: 7,977,376
Title: | Olopatadine formulations for topical nasal administration |
Abstract: | Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the nose are disclosed. The aqueous formulations contain approximately 0.6% (w/v) of olopatadine. |
Inventor(s): | Singh; Onkar N. (Arlington, TX), Wall; G. Michael (Fort Worth, TX), Jani; Rajni (Fort Worth, TX), Chowhan; Masood A. (Arlington, TX), Han; Wesley Wehsin (Arlington, TX) |
Assignee: | Novartis AG (Basal, CH) |
Application Number: | 11/703,373 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,977,376 |
Patent Claim Types: see list of patent claims | Composition; Formulation; |
Drugs Protected by US Patent 7,977,376
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,977,376
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 034619 | ⤷ Try a Trial | |||
Austria | 295149 | ⤷ Try a Trial | |||
Australia | 2002310461 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |